BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 14521621)

  • 1. Milder bleeding tendency in Glanzmann's thrombasthenia patients inheriting HPA-1b in the homozygous state.
    Ghosh K; Nair S; Kulkarni B; Shetty S; Mohanty D
    J Thromb Haemost; 2003 Oct; 1(10):2255-6. PubMed ID: 14521621
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of clinical phenotype of Glanzmann's thrombasthenia by thrombogenic mutations.
    Kannan M; Yadav BK; Ahmad F; Biswas A; Saxena R
    Clin Chim Acta; 2009 May; 403(1-2):156-8. PubMed ID: 19245802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human platelet alloantigen polymorphism in Glanzmann's thrombasthenia and its impact on the severity of the disease.
    Ghosh K; Kulkarni B; Nair S; Shetty S; Mohanty D
    Br J Haematol; 2002 Nov; 119(2):348-53. PubMed ID: 12406067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotyping provides a reliable tool for the determination of the platelet antigen system HPA-1 in Glanzmann's thrombasthenia.
    Pober M; Kyrle PA; Panzer S
    Br J Haematol; 1993 Sep; 85(1):112-5. PubMed ID: 8251377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glanzmann's thrombasthenia: report of a case and review of the literature.
    Sebastiano C; Bromberg M; Breen K; Hurford MT
    Int J Clin Exp Pathol; 2010 Apr; 3(4):443-7. PubMed ID: 20490335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinico-hematological and thromboelastographic profiles in glanzmann's thrombasthenia.
    Ahammad J; Kamath A; Shastry S; Chitlur M; Kurien A
    Blood Coagul Fibrinolysis; 2020 Jan; 31(1):29-34. PubMed ID: 31789664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of platelet membrane glycoprotein polymorphisms in Glanzmann thrombasthenia showed the French gypsy mutation in the alphaIIb gene to be strongly linked to the HPA-1b polymorphism in beta3.
    Jacquelin B; Tuleja E; Kunicki TJ; Nurden P; Nurden AT
    J Thromb Haemost; 2003 Mar; 1(3):573-5. PubMed ID: 12871468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of Glanzmann's thrombasthenia in Iran: identification of three novel mutations.
    Kazemi A; Abolghasemi H; Kazemzadeh S; Vahidi R; Faranoush M; Farsinejad A; Ala F
    Blood Coagul Fibrinolysis; 2017 Dec; 28(8):681-686. PubMed ID: 29084015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic tool for Glanzmann's thrombasthenia clinicopathologic spectrum.
    Ali N; Moiz B; Shaikh U; Adil S; Rizvi B; Rahman Y
    J Coll Physicians Surg Pak; 2008 Feb; 18(2):91-4. PubMed ID: 18454893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological study of platelet glycoproteins and alloantigens in families of patients with Glanzmann's thrombasthenia.
    Boizard-Boval B; Wautier JL; Gruel Y; Caen JP
    Nouv Rev Fr Hematol (1978); 1992; 34(1):93-8. PubMed ID: 1523103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral linkage between a new deletion polymorphism in intron 21 of the GP IIb gene and the HPA-3b (Bakb) determinant.
    Peyruchaud O; Nurden A; Bourre F
    Br J Haematol; 1995 Nov; 91(3):747-51. PubMed ID: 8555087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dental considerations for a Glanzmann's thrombasthenia patient: case report.
    Bisch FC; Bowen KJ; Hanson BS; Kudryk VL; Billman MA
    J Periodontol; 1996 May; 67(5):536-40. PubMed ID: 8724714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and molecular insights into Glanzmann's thrombasthenia in China.
    Zhou L; Jiang M; Shen H; You T; Ding Z; Cui Q; Ma Z; Yang F; Xie Z; Shi H; Su J; Cao L; Lin J; Yin J; Dai L; Wang H; Wang Z; Yu Z; Ruan C; Xia L
    Clin Genet; 2018 Aug; 94(2):213-220. PubMed ID: 29675921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal synthesis and expression of endothelial IIb/IIIa in Glanzmann's thrombasthenia.
    Giltay JC; Leeksma OC; Breederveld C; van Mourik JA
    Blood; 1987 Mar; 69(3):809-12. PubMed ID: 3545321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different biochemical expression pattern of platelet surface glycoproteins suggests molecular diversity of Glanzmann's thrombasthenia in Iran.
    Farsinejad A; Farajollahi MM; Kazemi A; Saemi N; Faranoush M
    Blood Coagul Fibrinolysis; 2013 Sep; 24(6):613-8. PubMed ID: 23912132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of recombinant factor VIla in a primigravida with Glanzmann's thrombasthenia during delivery.
    Kale A; Bayhan G; Yalinkaya A; Yayla M
    J Perinat Med; 2004; 32(5):456-8. PubMed ID: 15493726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the alloantigen Zwa (or P1A1) on human vascular smooth muscle cells and foreskin fibroblasts: a study on normal individuals and a patient with Glanzmann's thrombasthenia.
    Giltay JC; Brinkman HJ; von dem Borne AE; van Mourik JA
    Blood; 1989 Aug; 74(3):965-70. PubMed ID: 2473812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Homozygous Frameshift Mutation in ITGB3 Causes Glanzmann's Thrombasthenia.
    Li X; Xu J; Li Z; Song Y; Fei Y; Yang G; Tang A
    Acta Haematol; 2022; 145(1):78-83. PubMed ID: 34404052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NovoSeven (recombinant factor VIIa) for the treatment of bleeding episodes and perioperative management in patients with Glanzmann's thrombasthenia.
    Franchini M; Lippi G
    Expert Rev Hematol; 2014 Dec; 7(6):733-40. PubMed ID: 25387838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet phenotyping in carriers for Glanzmann's thrombasthenia: a simple screening test for assessment of the molecular defect.
    Morel-Kopp MC; Clemenceau S; Schlegel N; Lecompte T; Aurousseau MH; Kaplan C
    Transfus Med; 1995 Jun; 5(2):123-9. PubMed ID: 7655575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.